RT Journal Article
SR Electronic
T1 Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset
JF Thorax
JO Thorax
FD BMJ Publishing Group Ltd and British Thoracic Society
SP 83
OP 85
DO 10.1136/thorax-2022-219593
VO 79
IS 1
A1 Morgan, Helen
A1 Gysling, Savannah
A1 Navani, Neal
A1 Baldwin, David
A1 Hubbard, Richard
A1 O’Dowd, Emma
YR 2024
UL http://thorax.bmj.com/content/79/1/83.abstract
AB Early changes in lung cancer care can affect survival. Given the decrease in diagnosis during lockdowns, we calculated their impact on survival using National Lung Cancer Audit data. Percentage survival and HRs for death were compared between 2019 and lockdown periods of 2020. Decreased survival was observed from the first national lockdown onwards and within 90 days of diagnosis. HRs were highest for people diagnosed at the end of 2020 at 1.26 (95% CI 1.20 to 1.32) for death within 90 days and 1.51 (95% CI 1.42 to 1.60) for death between 91 and 270 days. Further work is needed on measures to mitigate this impact.